Search

Your search keyword '"Pavic, M."' showing total 3 results
Start Over Author "Pavic, M." Journal bulletin du cancer
3 results on '"Pavic, M."'

1. [Disseminated intravascular coagulation in solid tumours].

Author

Ferrand FR, Garcia-Hejl C, Moussaid Y, Schernberg A, Bidard FC, Pavic M, Khenifer S, and Stoclin A

Subjects
Anticoagulants therapeutic use, Blood Coagulation physiology, Coagulants therapeutic use, Factor VIIa therapeutic use, Humans, Neoplasms pathology, Neoplasms therapy, Platelet Transfusion, Prognosis, Recombinant Proteins therapeutic use, Risk Factors, Disseminated Intravascular Coagulation blood, Disseminated Intravascular Coagulation diagnosis, Disseminated Intravascular Coagulation epidemiology, Disseminated Intravascular Coagulation etiology, Disseminated Intravascular Coagulation physiopathology, Disseminated Intravascular Coagulation therapy, Neoplasms blood, Paraneoplastic Syndromes blood, Paraneoplastic Syndromes diagnosis, Paraneoplastic Syndromes etiology, Paraneoplastic Syndromes physiopathology, Paraneoplastic Syndromes therapy
Abstract

Disseminated intravascular coagulation (DIC) is a complex abnormality of hemostasis with dramatic consequences and long described as associated with tumors. Yet the diagnosis and management of paraneoplastic DIC are poorly defined. The purpose of this paper is to review DIC associated with solid tumors, at the pathophysiological and therapeutic levels in particular. We also report data from a recent retrospective series of patients with DIC in the context of a solid tumor, to illustrate the epidemiological, clinical and prognostic.

Published
2014
Full Text
View/download PDF

2. [Physical activity and cancer survival].

Author

Romieu I, Touillaud M, Ferrari P, Bignon YJ, Antoun S, Berthouze-Aranda S, Bachmann P, Duclos M, Ninot G, Romieu G, Sénesse P, Behrendt J, Balosso J, Pavic M, Kerbrat P, Serin D, Trédan O, and Fervers B

Subjects
Breast Neoplasms mortality, Breast Neoplasms physiopathology, Breast Neoplasms psychology, Breast Neoplasms rehabilitation, Cause of Death, Cohort Studies, Comorbidity, Cytokines metabolism, Exercise, Exercise Therapy, Fatigue etiology, Fatigue prevention & control, Female, Follow-Up Studies, Gonadal Steroid Hormones metabolism, Humans, Intercellular Signaling Peptides and Proteins metabolism, Meta-Analysis as Topic, Models, Biological, Multicenter Studies as Topic statistics & numerical data, Neoplasms mortality, Neoplasms psychology, Obesity epidemiology, Obesity physiopathology, Obesity therapy, Prospective Studies, Quality of Life, Randomized Controlled Trials as Topic statistics & numerical data, Survivors psychology, Motor Activity, Neoplasms rehabilitation
Abstract

Physical activity has been shown in large cohort studies to positively impact survival in cancer survivors. Existing randomized controlled trials showed a beneficial effect of physical activity on physical fitness, quality of life, anxiety and self-esteem; however, the small sample size, the short follow-up and the lack of standardization of physical activity intervention across studies impaired definite conclusion in terms of survival. Physical activity reduces adiposity and circulating estrogen levels and increases insulin sensitivity among other effects. A workshop was conducted at the International Agency for Research on Cancer in April 2011 to discuss the role of physical activity on cancer survival and the methodology to develop multicentre randomized intervention trials, including the type of physical activity to implement and its association with nutritional recommendations. The authors discuss the beneficial effect of physical activity on cancer survival with a main focus on breast cancer and report the conclusions from this workshop.

Published
2012
Full Text
View/download PDF

3. [2008 Standards, Options: recommendations for venous thromboembolic events (VTE) treatment and central venous catheter thrombosis (CVCT) management in cancer patients].

Author

Debourdeau P, Farge-Bancel D, Bosquet L, Kassab-Chahmi D, Cajfinger F, Desmurs-Clavel H, Desruennes E, Douard MC, Elias A, Elalamy I, Grange C, Hocini H, Kriegel I, Le Gal G, Lévesque H, Mahé I, Meyer G, Mismetti P, Pavic M, Quéré I, Renaudin JM, and Scrobohaci ML

Subjects
Anticoagulants adverse effects, Anticoagulants therapeutic use, Catheterization adverse effects, Fibrinolytic Agents therapeutic use, France, Heparin adverse effects, Heparin therapeutic use, Humans, Vena Cava Filters, Venous Thromboembolism prevention & control, Neoplasms complications, Venous Thromboembolism therapy
Abstract

The <> (SOR) project has been undertaken by the French National Federation of Cancer Centers (FNCLCC) is now part of the French National Cancer Institute. The project involves the development and updating of evidence-based Clinical Practice Guidelines (CPG) in oncology. In order to answer questions related to venous thromboembolic events (VTE) treatment and to central venous catheter thrombosis (CVCT) management in cancer patients, the SOR elaborated national guidelines, here presented in a short report. It results of a collaborative work with members from three learned societies ("société nationale française de médicine interne": SNFMI, "société française de médicine vasculaire": SFMV and "société française d'anesthésie-réanimation": SFAR).

Published
2008
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results